Santo Venture Capital GmbH

Santo Venture Capital GmbH is a German venture capital firm headquartered in Holzkirchen, Bavaria. Founded in 2011, the firm operates as a subsidiary of ATHOS Service GmbH, the family office of Thomas and Andreas Strüngmann, co-founders of Hexal AG. Santo Venture Capital focuses on investing in innovative companies across sectors such as healthcare, biopharmaceuticals, energy, clean technology, manufacturing, and logistics. The firm primarily invests in Series A and later-stage funding rounds, with average investments ranging from €5 million to €20 million.

The firm's investment strategy emphasizes transformative technologies and market leaders within its target industries. Santo Venture Capital has a history of backing high-growth European startups and scale-ups, providing both financial support and strategic guidance to its portfolio companies. As of November 2025, the firm has made 12 investments, with its most recent being in Clinomic as part of their Series B on April 8, 2025. Notable past investments include Liva Healthcare, which secured €8 million in funding from Santo Venture Capital and other investors in March 2019.

Santo Venture Capital's portfolio reflects its commitment to supporting companies that address significant challenges and opportunities within their respective industries. The firm's approach combines substantial financial backing with active involvement in the strategic direction of its investee companies, aiming to foster innovation and growth in sectors critical to the European economy.